Recursion ipo
WebRecursion's latest funding round was a PIPE for on October 25, 2024. Recursion's valuation in April 2024 was $2,878.43M. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. Revenue. WebApr 16, 2024 · Salt Lake City-based Recursion’s shares closed Friday at $31.30, giving Recursion a market value of more than $5 billion. It sold about 24 million shares on …
Recursion ipo
Did you know?
WebJun 17, 2024 · 33 months have passed since I spoke with Sweary and on June 16, WalkMe went public. After going out at $31 a share, the stock lost 7.1% of its value and ended its first day of trading with a ... WebDec 17, 2024 · You can see how Recursion’s IPO in April starts at the offering price of 18 and ended much higher. It’s a hot biotech stock, you can see it. MORE FROM FORBES ADVISOR Best Tax Software Of 2024...
WebIncluding the underwriters’ option of 3.6 million shares, Recursion sold 27.878 million shares at $18/share, raising nearly $502 million in the process (before IPO expenses). However, Recursion shares opened at $26.32 when actual trading began on April 16th, not at $18, a nearly 50% pop. And as of market close today, Recursion stock was priced at … WebApr 16, 2024 · Utah’s Recursion Goes Public – Announces Pricing of IPO. Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class …
WebApr 13, 2024 · Recursion is nearly ready to make its public debut, and the biotech set out what the potential raise might look like Monday. Recursion set its IPO terms, planning to raise $306 million by offering ... WebApr 27, 2024 · IPO: Recursion Pharmaceuticals Leverages Therapeutics Discovery With Machine Learning April 27, 2024 by Staff Twitter Recursion Pharmaceuticals Inc. uses machine learning to hunt for new therapies. The company raised $436 million in an upsized initial public offering priced at the top of a marketed range.
WebRecursion Pharmaceuticals has raised a total of $615.4M in funding over 17 rounds. Their latest funding was raised on Oct 25, 2024 from a Post-IPO Equity round. Recursion …
WebRecursion Pharmaceuticals - Crunchbase Company Profile & Funding Oops! There was a problem! There was an unexpected issue while trying to process your request. Please … karen collier shropshire councilWebMay 12, 2024 · IPO : Recursion upsized and completed its initial public offering in April 2024, raising gross and net proceeds of $501.8 million and $462.6 million, respectively. lawrence lovercheckWebRecursion Reports First Quarter 2024 Financials and Provides Business Updates •Strengthened balance sheet with the completion of a successful IPO •Purchased, built, … lawrence loop trailWebApr 16, 2024 · About Recursion. Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, … lawrence louis altomaroWebApr 16, 2024 · Recursion had initially planned to raise $306 million through the sale of 18 million shares priced in the range of $16 to $18 a share but raised the number of shares offered ahead of the IPO. Existing investors Baillie Gifford, on behalf of Scottish Mortgage Investment Trust, and Mubadala Investment Company had said they planned to buy up to ... lawrence lotzofWebFeb 17, 2024 · Recursion Pharmaceuticals completed its IPO in 2024, raising >$500m. The company is promising to revolutionize drug discovery with AI - although the evidence for … karen coffey coaching reviews criticismWebMar 22, 2024 · Recursion Pharmaceuticals, a Phase 2-ready biotech using machine learning to develop therapies for various indications, filed on Monday with the SEC to raise up to … lawrence lovett